CAS NO: | 72814-32-5 |
包装: | 50mg, 100mg, 250mg |
规格: | ≥98% |
BW245C has potent platelet anti-aggregating actions following parenteral or orally bioavailable administration which makes this hydantoin a potentially-useful anti-thrombotic prostaglandin analogue. References: Ahmad AS. PGD2 DP1 receptor stimulation following stroke ameliorates cerebral blood flow and outcomes. Neuroscience. 2014 Oct 24;279:260-8. doi: 10.1016/j.neuroscience.2014.08.050. Epub 2014 Sep 10. PubMed PMID: 25218962.
纯度:≥98%
CAS:72814-32-5